Simões Eric A F, Suss Robert J, Raje Dhananjay
Department of Pediatric Infectious Diseases, University of Colorado School of Medicine and Children's Hospital Colorado Aurora, Aurora, Colorado, USA.
Samshoma Medical Research Inc, Denver, Colorado, USA.
J Infect Dis. 2025 Jul 16;232(Supplement_1):S19-S28. doi: 10.1093/infdis/jiaf266.
Among older adults, respiratory syncytial virus (RSV) infection is a known cause of hospitalization, intensive care unit (ICU) admission, and mortality risk. The severity of the disease burden of human metapneumovirus (HMPV) among older adults is less well recognized. The objective of this study was to better understand risk factors for hospitalization with and outcomes in adults ≥50 years of age infected with HMPV and to compare these with RSV risk factors and outcomes.
This was a retrospective cohort analysis of adults 50-88 years of age in 93 medical facilities in the Colorado Hospital Association database between 2016 and 2023. RSV and HMPV, other respiratory infections, and comorbidities were identified using International Classification of Diseases, Tenth Revision codes and grouped by increasing numbers of comorbidities. Multivariate logistic regression was performed to estimate the risk of the various predictors on ICU admission, and mortality for both HMPV and RSV infection, adjusted for sex, age, and comorbidity.
The highest risk for ICU admission was chronic obstructive pulmonary disease (COPD) (RSV: adjusted odds ratio [aOR], 2.24 [95% confidence interval {CI}, 1.81-2.77], P < .001; HMPV: aOR, 2.99 [95% CI, 2.13-4.19], P < .001), and those with neuromuscular disease without dementia (RSV: aOR, 2.33 [95% CI, 1.98-2.75], P < .001; HMPV: aOR, 2.22 [95% CI, 1.75-2.80], P < .001). Age significantly increased the odds of mortality among RSV-infected but not HMPV-infected patients. Neurological disorders with dementia were the highest comorbid risk factor for RSV mortality (aOR, 4.16 [95% CI, 3.01-5.77]; P < .001), in contrast to COPD for HMPV mortality (aOR, 12.44 [95% CI, 3.02-51.17]; P < .001).
HMPV infection poses a unique disease burden with specific high-risk comorbidities among the older adult population distinct from that of RSV and warrants further study.
在老年人中,呼吸道合胞病毒(RSV)感染是导致住院、入住重症监护病房(ICU)和死亡风险的已知原因。人们对人偏肺病毒(HMPV)在老年人中疾病负担的严重程度了解较少。本研究的目的是更好地了解≥50岁的HMPV感染成人住院的风险因素和结局,并将这些与RSV的风险因素和结局进行比较。
这是一项对2016年至2023年科罗拉多医院协会数据库中93家医疗机构50-88岁成年人的回顾性队列分析。使用国际疾病分类第十版编码识别RSV和HMPV、其他呼吸道感染及合并症,并按合并症数量增加进行分组。进行多因素逻辑回归以估计各种预测因素对ICU入院以及HMPV和RSV感染患者死亡率的风险,并根据性别、年龄和合并症进行调整。
ICU入院的最高风险因素是慢性阻塞性肺疾病(COPD)(RSV:调整优势比[aOR],2.24[95%置信区间{CI},1.81-2.77],P<.001;HMPV:aOR,2.99[95%CI,2.13-4.19],P<.001),以及无痴呆的神经肌肉疾病患者(RSV:aOR,2.33[95%CI,1.98-2.75],P<.001;HMPV:aOR,2.22[95%CI,1.75-2.80],P<.001)。年龄显著增加了RSV感染患者而非HMPV感染患者的死亡几率。伴有痴呆的神经系统疾病是RSV死亡的最高合并症风险因素(aOR,4.16[95%CI,3.01-5.77];P<.001),而COPD是HMPV死亡的最高合并症风险因素(aOR,12.44[95%CI,3.02-51.17];P<.001)。
HMPV感染在老年人群中造成了独特的疾病负担,具有与RSV不同的特定高风险合并症,值得进一步研究。